Delbanco Thomas MD - Boston, Massachusetts 02215

Business Name:	Delbanco Thomas MD
Contact Person:	Thomas Delbanco
Address:	330 Brookline Avenue, Boston, Massachusetts 02215
Phone Number:	(617) 735-2422
Annual Revenue (USD):	$500.000 to $999.999
Location Type:	Single Location
Employee Number:	1 to 4
Business Type:	B2C (Business to Consumer)
Business Category:	Hospitals
SIC Code:	8062
NAICS Code:	6211110
Share This Business:
Related Businesses:	Decision Support - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Beth Israel Deaconess - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Arnold Pain Center - Boston, MA 02215 N E Deaconess Hospital - Boston, MA 02215 Deaconess Medical Center - Boston, MA 02215 Boston Medical Center - Boston, MA 02215 Brigham Womens Hospital - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Comprehensive Epilepsy - Boston, MA 02215 Beth Israel Medical Center - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Beth Israel Deaconess Bus Office - Boston, MA 02215 Beth Israel Deaconess Department Of Medicine - Boston, MA 02215 Beth Israel Deaconess Medical Center Inc - Boston, MA 02215 Boston Medical Center Corporation - Boston, MA 02215

The company Delbanco Thomas MD provides B2C services in the form of Hospitals from its single location in Massachusetts. 1 to 4 employees work for Delbanco Thomas MD, and the business now earns $500.000 to $999.999 per annum.

Delbanco Thomas MD was launched in 0 and is classified under SIC code and category 8062 , and NAICS number and grouping 6211110 . To contact Delbanco Thomas MD, please call Thomas Delbanco with the phone number (617) 735-2422 or visit its single location at 330 Brookline Avenue in Boston, Massachusetts 02215.

The location of the single location can also be found using the coordinates 42.340759,-71.105216. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.